ישראל - עברית - Ministry of Health

fischer pharmaceuticals ltd - oxybuprocaine hydrochloride - טיפות - oxybuprocaine hydrochloride 0.4 % - oxybuprocaine - oxybuprocaine - local anesthetic

ישראל - עברית - Ministry of Health

cts ltd - chloroprocaine hydrochloride - תמיסה להזרקה - chloroprocaine hydrochloride 10 mg/ml - chloroprocaine

ישראל - עברית - Ministry of Health

kamada ltd, israel - plasma protein fraction - תמיסה לאינפוזיה - plasma protein fraction 200 mg/ml - protein c - protein c - restoration and maintenance of circulating blood volume where volume deficiency has been demonstrated and use of a colloid is appropriate. the choice of albumin rather than artificial colloid will depend on the clinical situation of the individual patient, based on official recommendation.

ישראל - עברית - Ministry of Health

comex ltd - procaine benzylpenicillin - תרחיף להזרקה - procaine benzylpenicillin 300 mg/ml

ישראל - עברית - Ministry of Health

comex ltd - dihydrostreptomycin sulfate; procaine benzylpenicillin - תרחיף להזרקה - procaine benzylpenicillin 200 mg/ml; dihydrostreptomycin sulfate 250 mg/ml

ישראל - עברית - Ministry of Health

intervet ( israel) ltd - dihydrostreptomycin as sulfate; nafcillin as sodium; procaine benzylpenicillin - משחה - procaine benzylpenicillin 300 mg / 3 g; dihydrostreptomycin as sulfate 100 mg / 3 g; nafcillin as sodium 100 mg / 3 g

ישראל - עברית - Ministry of Health

intervet ( israel) ltd - dihydrostreptomycin sulfate; nafcillin as nafcillin sodium; procaine benzylpenicillin - משחה - procaine benzylpenicillin 300 mg / 3 g; dihydrostreptomycin sulfate 100 mg / 3 g; nafcillin as nafcillin sodium 100 mg / 3 g

ישראל - עברית - Ministry of Health

merck sharp & dohme israel ltd - protein l1 (type 11); protein l1 (type 16); protein l1 (type 18); protein l1 (type 6) - תרחיף להזרקה - protein l1 (type 18) 20 mcg / 0.5 ml; protein l1 (type 6) 20 mcg / 0.5 ml; protein l1 (type 11) 40 mcg / 0.5 ml; protein l1 (type 16) 40 mcg / 0.5 ml - combinations - combinations - gardasil is indicated in females aged 9 through 45 years* for the prevention of cervical, vulvar, vaginal cancer, precancerous or dysplastic lesions, genital warts, and infection caused by human papillomavirus (hpv) types 6, 11, 16, and 18 (which are included in the vaccine). gardasil is indicated in males 9 through 26 years* of age for the prevention of anal cancer, precancerous or dysplastic lesions, external genital lesions and infection caused by hpv types 6, 11, 16, and 18 (which are included in the vaccine). *immunogenicity studies have been conducted to link efficacy in females and males aged 16 to 26 years to the younger populations..

ישראל - עברית - Ministry of Health

glaxo smith kline (israel) ltd - neisseria meningitides group b strain nz98/254; neisseria meningitidis group b fhbp fusion protein; neisseria meningitidis group b nada protein; neisseria meningitidis group b nhba fusion protein - תרחיף להזרקה - neisseria meningitides group b strain nz98/254 25 mcg; neisseria meningitidis group b fhbp fusion protein 50 mcg; neisseria meningitidis group b nada protein 50 mcg; neisseria meningitidis group b nhba fusion protein 50 mcg - meningococcus b, outer membrane vesicle vaccine

ישראל - עברית - Ministry of Health

merck sharp & dohme (israel - 1996) company ltd, israel - hpv type 11 l1 protein; hpv type 16 l1 protein; hpv type 18 l1 protein; hpv type 31 l1 protein; hpv type 33 l1 protein; hpv type 45 l1 protein; hpv type 52 l1 protein; hpv type 58 l1 protein; hpv type 6 l1 protein - תרחיף להזרקה - hpv type 58 l1 protein 20 mcg / 0.5 ml; hpv type 52 l1 protein 20 mcg / 0.5 ml; hpv type 45 l1 protein 20 mcg / 0.5 ml; hpv type 33 l1 protein 20 mcg / 0.5 ml; hpv type 31 l1 protein 20 mcg / 0.5 ml; hpv type 18 l1 protein 40 mcg / 0.5 ml; hpv type 16 l1 protein 60 mcg / 0.5 ml; hpv type 11 l1 protein 40 mcg / 0.5 ml; hpv type 6 l1 protein 30 mcg / 0.5 ml - papillomavirus (human types 6, 11, 16, 18, 31, 33, 45, 52, 58)